FDA Inspection 1111976 — Virbac Corporation

Virbac Corporation — FEI 1944921

The FDA completed an inspection of Virbac Corporation on November 25, 2019 in Bridgeton, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 25, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bridgeton, MO (United States)